LOGO
  • About
  • Science
  • Patents
  • Academic Program
  • Blog
  • Industry News
  • e·Meditation
  • English
    • English
    • Русский
    • العربية
    • Deutsch
    • Español
    • Français
    • हिन्दी
    • 日本語
    • 한국어
    • Polski
    • Português
    • 简体中文
  1. Home
  2. blog

Trump signs order to speed review of psychedelics, including ibogaine

President Trump has signed an order to accelerate federal review of psychedelic drugs, including ibogaine, a substance backed by some veterans but linked to dangerous heart risks.

20 Apr 2026

brainjo raises €2M to advance VR adjunct for pediatric ADHD therapy

Regensburg startup brainjo raised €2 million in a seed round led by HTGF to fund clinical trials and regulatory work for a VR-based DiGA aimed at children with ADHD, developed with MEDICE Health Family and targeting approval in 2028.

20 Apr 2026

Tomsk Polytechnic University develops magnetoelectric nanoparticles for non‑invasive brain stimulation

Tomsk Polytechnic University researchers report sub‑30 nm magnetoelectric nanoparticles (manganese ferrite core, barium titanate shell) that, in lab tests, tripled neuronal calcium influx and activated 20% more cells; the team says particles are biocompatible at therapeutic concentrations and that in vivo studies are next.

20 Apr 2026

FDA clears Cala kIQ Plus wearable for Parkinson’s hand tremor

The FDA has cleared Cala Health’s Cala kIQ Plus, a wrist‑worn TAPS neurostimulation device for hand tremor in Parkinson’s and essential tremor; company data from 78 patients will be presented at AAN 2026.

19 Apr 2026

Mobia Medical markets Vivistim paired VNS system for chronic ischemic stroke

Mobia Medical markets the FDA-approved Vivistim Paired VNS System, an implanted vagus nerve stimulator the company says improves upper-limb function in chronic ischemic stroke survivors. The firm describes the device as delivering stimulation paired with movement to promote neuroplasticity.

19 Apr 2026

Year-long aerobic exercise cut long-term cortisol in randomized trial, but most heart‑and‑brain markers were unchanged

A randomized year-long trial of 130 adults found 150 minutes/week of aerobic exercise reduced hair cortisol, a multi-month marker of systemic stress, while cholesterol, inflammation, vascular measures and MRI stress responses showed no clear change.

19 Apr 2026
← 1 2 ... 5 6 7 8 9 10 11 ... 20 21 →

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

  • Announcements
  • Blog
  • Articles
  • Industry News
  • Science News

Archives

  • January 2022
  • January 2024
  • January 2025
  • January 2026
  • February 2023
  • February 2024
  • February 2026
  • March 2023
  • March 2024
  • March 2026
  • April 2025
  • April 2026
  • May 2020
  • May 2022
  • May 2026
  • June 2019
  • June 2022
  • June 2023
  • June 2025
  • June 2026
  • July 2022
  • July 2024
  • July 2025
  • August 2022
  • August 2025
  • September 2020
  • September 2024
  • September 2025
  • October 2019
  • October 2021
  • October 2022
  • October 2024
  • October 2025
  • November 2022
  • December 2021
  • December 2022

🍪 We use cookies

We use cookies to enhance your browsing experience and analyze our traffic. Privacy Policy

BrainPatch® and e·Meditation® is a registered trademarks of BrainPatch Ltd.

Follow Us

Site map

  • Home
  • About
  • News
  • Industry News
  • Companies
  • Science
  • Patents
  • Academic Program
  • e·Meditation Device

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • sales@brainpatch.ai
  •  

Contact Us

  • BrainPatch Limited,
    9 Hills Road, CB2 1GE, Cambridge, United Kingdom
    Company Number 11271285
    VAT GB310938419
  • BrainPatch Limited,
    Landscape House, Baldonnell Business Park, Baldonnell, Dublin, D223PK7, Ireland
    Company Number 678405

© 2026 All rights reserved. Created by: BrainPatch Ltd.

Privacy Policy